Are children with prolonged fever at a higher risk for serious illness? A prospective observational study.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
08 2023
Historique:
received: 15 01 2023
accepted: 10 04 2023
medline: 21 7 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: ppublish

Résumé

To describe the characteristics and clinical outcomes of children with fever ≥5 days presenting to emergency departments (EDs). Prospective observational study. 12 European EDs. Consecutive febrile children <18 years between January 2017 and April 2018. Children with fever ≥5 days and their risks for serious bacterial infection (SBI) were compared with children with fever <5 days, including diagnostic accuracy of non-specific symptoms, warning signs and C-reactive protein (CRP; mg/L). SBI and other non-infectious serious illness. 3778/35 705 (10.6%) of febrile children had fever ≥5 days. Incidence of SBI in children with fever ≥5 days was higher than in those with fever <5 days (8.4% vs 5.7%). Triage urgency, life-saving interventions and intensive care admissions were similar for fever ≥5 days and <5 days. Several warning signs had good rule in value for SBI with specificities >0.90, but were observed infrequently (range: 0.4%-17%). Absence of warning signs was not sufficiently reliable to rule out SBI (sensitivity 0.92 (95% CI 0.87-0.95), negative likelihood ratio (LR) 0.34 (0.22-0.54)). CRP <20 mg/L was useful for ruling out SBI (negative LR 0.16 (0.11-0.24)). There were 66 cases (1.7%) of non-infectious serious illnesses, including 21 cases of Kawasaki disease (0.6%), 28 inflammatory conditions (0.7%) and 4 malignancies. Children with prolonged fever have a higher risk of SBI, warranting a careful clinical assessment and diagnostic workup. Warning signs of SBI occurred infrequently but, if present, increased the likelihood of SBI. Although rare, clinicians should consider important non-infectious causes of prolonged fever.

Identifiants

pubmed: 37185174
pii: archdischild-2023-325343
doi: 10.1136/archdischild-2023-325343
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

632-639

Subventions

Organisme : Department of Health
ID : ACL-2018-021-007
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Ruud G Nijman (RG)

Department of Paediatric Emergency Medicine, Division of Medicine, St. Mary's hospital - Imperial College NHS Healthcare Trust, London, UK r.nijman@imperial.ac.uk.
Faculty of Medicine, Department of Infectious Diseases, Section of Paediatric Infectious Diseases, Imperial College London, London, UK.
Centre for Paediatrics and Child Health, Imperial College London, London, UK.

Chantal D Tan (CD)

Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.

Nienke N Hagedoorn (NN)

Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.

Daan Nieboer (D)

Department of Public Health, Erasmus University Medical Centre, Rotterdam, Netherlands.

Jethro Adam Herberg (JA)

Faculty of Medicine, Department of Infectious Diseases, Section of Paediatric Infectious Diseases, Imperial College London, London, UK.

Anda Balode (A)

Department of Pediatrics, Children's Clinical University Hospital, Rīgas Stradiņa Universitāte, Riga, Latvia.

Ulrich von Both (U)

Division of Paediatric Infectious Diseases, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilian-University, Munich, Germany.
Partner site Munich, German Centre for Infection Research, Munich, Germany.

Enitan D Carrol (ED)

Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

Irini Eleftheriou (I)

Second Department of Paediatrics, P & A Kyriakou Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Marieke Emonts (M)

Paediatric Immunology, Infectious Diseases & Allergy, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, UK.

Michiel van der Flier (M)

Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands.
Paediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, Netherlands.
Section Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands.

Ronald de Groot (R)

Paediatric Infectious Diseases and Immunology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, Netherlands.
Section Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands.

Benno Kohlmaier (B)

Department of General Paediatrics, Medical University of Graz, Graz, Austria.

Emma Lim (E)

Paediatric Immunology, Infectious Diseases & Allergy, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Federico Martinón-Torres (F)

Genetics, Vaccines, Infections and Paediatrics Research group (GENVIP), Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.

Marko Pokorn (M)

Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Franc Strle (F)

Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Maria Tsolia (M)

Second Department of Paediatrics, P & A Kyriakou Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Shunmay Yeung (S)

Clinical Research Department, Faculty of Tropical and Infectious Disease, London School of Hygiene and Tropical Medicine, London, UK.

Joany M Zachariasse (JM)

Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.

Dace Zavadska (D)

Department of Pediatrics, Children's Clinical University Hospital, Rīgas Stradiņa Universitāte, Riga, Latvia.

Werner Zenz (W)

Department of General Paediatrics, Medical University of Graz, Graz, Austria.

Michael Levin (M)

Faculty of Medicine, Department of Infectious Diseases, Section of Paediatric Infectious Diseases, Imperial College London, London, UK.

Clementien L Vermont (CL)

Department of Paediatric Infectious Diseases and Immunology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.

Henriette A Moll (HA)

Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.

Ian K Maconochie (IK)

Department of Paediatric Emergency Medicine, Division of Medicine, St. Mary's hospital - Imperial College NHS Healthcare Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH